Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DERMATOLOGY THERAPEUTICS DEVICES INDUSTRY
2.1 Summary about Dermatology Therapeutics Devices Industry
2.2 Dermatology Therapeutics Devices Market Trends
2.2.1 Dermatology Therapeutics Devices Production & Consumption Trends
2.2.2 Dermatology Therapeutics Devices Demand Structure Trends
2.3 Dermatology Therapeutics Devices Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Laser
4.2.2 Ultraviolet Radiation
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Beauty Salon
4.3.3 Homehold
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Laser
5.2.2 Ultraviolet Radiation
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Beauty Salon
5.3.3 Homehold
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Laser
6.2.2 Ultraviolet Radiation
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Beauty Salon
6.3.3 Homehold
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Laser
7.2.2 Ultraviolet Radiation
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Beauty Salon
7.3.3 Homehold
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Laser
8.2.2 Ultraviolet Radiation
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Beauty Salon
8.3.3 Homehold
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Laser
9.2.2 Ultraviolet Radiation
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Beauty Salon
9.3.3 Homehold
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Alma Lasers
10.1.2 Cutera
10.1.3 Cynosure
10.1.4 Genesis Biosystems, Inc
10.1.5 HEINE Optotechnik GmbH & Co. KG
10.1.6 Michelson Diagnostics
10.1.7 Solta Medical
10.1.8 3Gen
10.1.9 Canfield
10.1.10 ICON plc
10.2 Dermatology Therapeutics Devices Sales Date of Major Players (2017-2020e)
10.2.1 Alma Lasers
10.2.2 Cutera
10.2.3 Cynosure
10.2.4 Genesis Biosystems, Inc
10.2.5 HEINE Optotechnik GmbH & Co. KG
10.2.6 Michelson Diagnostics
10.2.7 Solta Medical
10.2.8 3Gen
10.2.9 Canfield
10.2.10 ICON plc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
